Atreca
Dr. Gould was previously Executive Director, Translational Oncology at Genentech, where he led a team focused on developing tumor specific antibodies weaponized with immune-targeting arms or drug payloads for use in both hematologic and solid tumors. Prior to joining Genentech, Dr. Gould served as Senior Director, Oncology at Curis.
Dr. Gould received his Ph.D. from the University of Connecticut Health Center in Development Biology and held postdoctoral fellowships at the University of California San Francisco in the department of Orthopedic Surgery, and University of Virginia in the Department of Biology.
This person is not in any teams
This person is not in any offices
Atreca
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics.